Drug Research Group Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2020 | 1,048,653 | 981,977 | 66,676 | 22.9 | 55% |
| 2021 | 1,085,400 | 966,555 | 118,845 | 25.9 | 57% |
| 2022 | 255,612 | 996,850 | −741,238 | 15.1 | 54% |
| 2023 | 576,423 | 997,184 | −420,761 | 10.2 | 51% |
In its most recent public year (2023), this organization spent $420,761 more than it brought in. Its reserves stood at about 10.2 months of spending, down from 22.9 in 2020. Staff pay was 51% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works